---
schema_version: "secwatch.filing_event.v1"
accession: "0001013762-25-002132"
form_type: "8-K"
ticker: "DMNIF"
cik: "0002000640"
company_name: "Damon Inc."
filed_at: "2025-03-25T23:59:59+00:00"
generated_at: "2026-05-24T06:10:42.729856+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Damon receives Nasdaq MVPHS non-compliance notice; closes dilutive $15M unit offering

## Summary
- Nasdaq notified Damon on March 20 that MVPHS was below $15M for 30 consecutive business days; compliance period until Sept 16, 2025.
- Closed underwriting with Maxim Group: 126.9M units at $0.13/unit, each unit = 1 common share + 1 Series A warrant; net proceeds ~$15M.
- Series A warrants exercisable at $0.195/share, but alternate cashless exercise allows 2.5 shares for no cash – company expects no additional funds from warrant exercise.
- Consent agreement with Streeterville: uses ~14% of net proceeds ($2.1M) to prepay note; East West note terminated.
- Settled with former advisor Peikin: pays $2.515M total, $1.515M cash, $1M deferred; Peikin surrenders 1,255,230 shares for cancellation.

## SEC filing metadata
- accession: 0001013762-25-002132
- form_type: 8-K
- ticker: DMNIF
- cik: 0002000640
- company_name: Damon Inc.
- filed_at: 2025-03-25T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 1.02, 3.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2000640/000101376225002132/0001013762-25-002132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2000640/000101376225002132/ea0235406-8k_damon.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001013762-25-002132
- JSON: https://secwatch.observer/filing/0001013762-25-002132.json
- Plain text: https://secwatch.observer/filing/0001013762-25-002132.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
